TANGANYIKA DUDLEY: Open Payments
NPI 1962066688 · PARIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 15 payments from 9 companies in 2025. Trend: 2023 $321 · 2024 $169 · 2025 $350
Food & beverage: $336Education: $14
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $125 |
| Calliditas Therapeutics US Inc. | 3 | $54 |
| Travere Therapeutics, Inc. | 3 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Novo Nordisk Inc | 1 | $17 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| OPKO Pharmaceuticals, LLC | 1 | $14 |
Products named: SYMPLICITY G3, TARPEYO, JYNARQUE, FARXIGA, Wegovy, JARDIANCE, RAYALDEE.
Industry payments across TX — which companies pay providers there.
